Key statistics
On Thursday, Collegium Pharmaceutical Inc (COLL:NSQ) closed at 38.93, -4.93% below its 52-week high of 40.95, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 39.43 |
---|---|
High | 39.45 |
Low | 38.00 |
Bid | 33.39 |
Offer | 39.57 |
Previous close | 38.78 |
Average volume | 257.89k |
---|---|
Shares outstanding | 32.21m |
Free float | 31.79m |
P/E (TTM) | 16.88 |
Market cap | 1.25bn USD |
EPS (TTM) | 2.30 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
- Collegium Completes Acquisition of Ironshore Therapeutics
- Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
- Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024
- Collegium Reports Second Quarter 2024 Financial Results
- Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology
- Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024
- Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise
- Collegium to Participate in Jefferies Global Healthcare Conference
- Collegium Announces $35 Million Accelerated Share Repurchase Program
- Collegium Reports First Quarter 2024 Financial Results
More ▼